ATC codes:
J04BA02
EMLc
Indication
Leprosy
ICD11 code:
1B50.Z
INN
Dapsone
Medicine type
Chemical agent
List type
Core
(EML)
(EMLc)
(EMLc)
Additional notes
Medicines used in the treatment of leprosy should never be used except in combination. Combination therapy is essential to prevent the emergence of drug resistance. Colour-coded blister packs (MDT blister packs) containing standard two-medicine (paucibacillary leprosy) or three-medicine (multibacillary leprosy) combination for adult and childhood leprosy should be used. MDT blister packs can be supplied free of charge through WHO.
Formulations
Oral > Solid:
100 mg tablet ;
50 mg tablet ;
25 mg tablet
EML status history
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
Dapsone was endorsed as an essential medicine for children by the EMLc Subcommittee and included on the first EMLc in 2007 for the treatment of leprosy.